Navigation Links
Fat-Burning Chemical Points to New Weight-Loss Drug
Date:2/2/2010

Results of lab tests with mice suggest promising new direction for research, scientists say

TUESDAY, Feb. 2 (HealthDay News) -- American scientists say they may have found a new way to trick the body into burning more fat.

Mice that were given a chemical that blocks the function of an enzyme called Fyn kinase burned more fatty acids and expended more energy, which made them leaner. This and other metabolic improvements, including increased insulin sensitivity, were because of higher levels of the "master energy switch" AMPK in the rodents' fat and muscle tissue.

The findings suggest that Fyn kinase may offer a target for a new kind of weight-loss drug, said the researchers at the Albert Einstein College of Medicine and Neuroscience. The study appears in the Feb. 3 issue of the journal Cell Metabolism.

"When there is an imbalance between what we eat and what we burn," the result is obesity, team leader Claire Bastie said in a news release from the journal. "And the problem of obesity is not going away. This is a new mechanism to help the body burn extra energy."

The experimental drug used to block Fyn kinase in the mice isn't an ideal candidate for clinical trials in humans because both Fyn kinase and AMPK have effects in the brain as well as in fat and muscle.

"Our next goal is to design [a drug] extremely specific to muscle and [fat]," Bastie said.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about weight loss.



-- Robert Preidt



SOURCE: Cell Press, news release, Feb 2, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Pacific Shore Holdings, Inc. Launches Burner Balm a Revolutionary, Energy-Boosting, Appetite-Suppressing, Fat-Burning Lip Balm - Natural, Green and Cost-Effective - Featured on NBCs Today Show
2. Impaired fat-burning gene worsens diabetes
3. Mount Sinai finds prenatal exposure to certain chemicals affects childhood neurodevelopment
4. Biochemical profile may help diagnose, determine aggressiveness of prostate cancer
5. Flame-Retardant Chemical Linked to Conception Problems
6. Poop dermatitis linked to fashionable toilet seats, harsh chemicals
7. Stain repellent chemical linked to thyroid disease in adults
8. FDAs BPA Announcement an About Face on the Toxic Chemical
9. Chemical BPA Linked to Heart Disease Risk
10. Breast Growth in Boys Might Be Linked to Plastics Chemical
11. When Will FDA Speak Out on Toxic Plastics Chemical BPA?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... Splashtop Inc., the worldwide leader in high performance ... the leading provider of secure mobile remote access solution for Japan enterprises. ... remote access solution. Splashtop for CACHATTO will be available as an integrated ...
(Date:5/31/2016)... ... ... Twenty years ago it was revolutionary: enabling the people who hear distressing voices ... But this approach has proven transformative, both for people who hear voices and for ... is used around the world, but it still lags in the United States. , ...
(Date:5/31/2016)... ... May 31, 2016 , ... When ... he knew it was something that contractors should have at their disposal on ... gets,” says Butch, CertainTeed’s Director of Contractor Programs. , As a result, ...
(Date:5/31/2016)... Severna Park, Maryland (PRWEB) , ... May 31, ... ... the ability to attribute calls back to particular advertising campaigns, to monitor the ... teams so that they can maximize conversions and revenue. The software allows customers ...
(Date:5/31/2016)... ... May 31, 2016 , ... Effective leaders not only drive service to ... a whole. On June 2, Northbound CEO Mike Neatherton and COO Paul Alexander will ... the opening plenary on “Leadership: The Journey to Authenticity” with Onsite Workshops CEO Miles ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharmaceutical company focused on late-stage drug development, ... Dexcel Pharma of pivotal batches required for ... Drug Administration (FDA). This follows Kitov,s announcement ... III trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... -- A key trend that will boost ... new treatments. Cardax, a development stage life sciences company, ... is expected to fulfil large unmet medical needs in ... to develop new treatments for osteoarthritis. One such study ... osteoarthritis are being investigated, and early trials of stem-cell ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
Breaking Medicine Technology: